Go to home page - New Zealand Food Safety Authority.
Page content. Site access keysMain Menu
| Advanced Search
Te Pou Oranga Kai O Aotearoa

Response to Waikato Business News article ‘A2 milk producers convinced it’s “extra healthy”’ (October ’05)

03 November ‘05

Sir,

Readers of your story (A2 milk producers convinced it’s “extra healthy”, 25 October) have been misled as to the outcome of the independent review commissioned by the New Zealand Food Safety Authority.

The statement that the review “determined there was “striking and significant” evidence supporting the A2 hypothesis” is false.

As we stated in August last year, our advice to consumers is to keep drinking milk as a nutritious food, no matter whether it’s A1 or A2, as there is no food safety issue with either type of milk.

Professor Boyd Swinburn’s review of the literature on possible benefits of A2 milk over A1 concluded that there is insufficient overall evidence that either milk has benefits over the other. However, it does note that further work is needed in this area to determine any causative relationships between types of milks and certain diseases.

The report, Beta casein A1 and A2 milk and human health, available in full from the NZFSA web site, examines whether some milk proteins might cause or protect against type 1 diabetes, heart disease, schizophrenia and autism.

Professor Swinburn concludes in the report: “The hypothesis that a high intake of milk containing A1 β-casein promotes conditions as heterogeneous as DM-1 [type 1 diabetes], IHD [Ischaemic heart disease], schizophrenia and autism is intriguing and potentially important. There is some very suggestive evidence from ecological studies for DM-1 and IHD, and there is certainly a possibility that the A1/A2 composition of milk is a factor in the etiology of these conditions. However, this hypothesis has yet to be backed by good human trials. The evidence in relation to autism comes mainly from poorly controlled clinical trials of gluten-free, casein-free diets where some improvement is noted in the autism characteristics and behaviours. The evidence in relation to schizophrenia is very minimal.”

Sandra Daly

Acting Executive Director

New Zealand Food Safety Authority

All information on this website is subject to a disclaimer.
Contact for enquiries

New Zealand Food Safety Authority
68-86 Jervois Quay
PO Box 2835
Wellington
NEW ZEALAND

Phone: +64 4 894 2500
Fax: +64 4 894 2501

Contact this person